✦ LIBER ✦

Serum CXC ligand 5 is a new marker of subclinical atherosclerosis in type 2 diabetes

✍ Scribed by Lili Chen; Zhen Yang; Bin Lu; Qin Li; Zi Ye; Min He; Ying Huang; Xuanchun Wang; Zhaoyun Zhang; Jie Wen; Chao Liu; Shen Qu; Renming Hu

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Metabolic syndrome is not associated wit

✍ M. Fukui; H. Ose; Y. Kitagawa; K. Kamiuchi; I. Nakayama; M. Ohta; H. Obayashi; M 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 272 KB

N-terminal pro-brain natriuretic peptide

✍ Takafumi Senmaru, Michiaki Fukui, Muhei Tanaka, Kazumi Sakabe… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 177 KB

Clinical significance of circulating hep

✍ K. Satani; H. Konya; T. Hamaguchi; A. Umehara; T. Katsuno; T. Ishikawa; K. Kohri 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB

Plasma concentration of visfatin is a ne

✍ Young Sun Kang; Hye Kyoung Song; Mi Hwa Lee; Gang Jee Ko; Dae Ryong Cha 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 481 KB

AS-279: Serum Fibroblast Growth Factor 2

✍ A-Ra Cho; Seung-Woon Rha; Sang-Ho Park; Hyeok-Gyu Lee; Se-Whan Lee; Won-Yong Shi 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 505 KB

Serum carboxy-terminal propeptide of typ

✍ Sang-Hyun Ihm; Ho-Joong Youn; Dong-Il Shin; Sung-Won Jang; Chul-Soo Park; Pum Jo 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 127 KB